Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety, Efficacy and Pharmacokinetic Study of PRLX 93936 in Patients With Multiple Myeloma

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2013 by Prolexys Pharmaceuticals.
Recruitment status was  Recruiting
Information provided by (Responsible Party):
Prolexys Pharmaceuticals Identifier:
First received: September 18, 2012
Last updated: May 31, 2013
Last verified: May 2013
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2014
  Estimated Primary Completion Date: March 2014 (Final data collection date for primary outcome measure)